Two or Six cm From Pylorus at Laparoscopic Sleeve Gastrectomy

Randomized controlled trial comparing between two technique of laparoscopic sleeve gastrectomy for treatment of morbid obesity. In the first technique the investigators started dissection of gastrocolic ligament 6 cm from pylorus and in the second one the distance was only 2 cm. The main primary outcome measure was weight loss.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Morbid Obesity Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Obesity Obesity, Morbid Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Gastroenterology Surgical Center

Al Mansurah, Dakahlia Governorate, 35516, Egypt

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

morbid obesity with body mass index more than 40 or 35 with at least one comorbidity

Exclusion criteria

extreme of age less than 18 or over 65 years contraindications to laparoscopy

Treatment and study plan

distance of dissection of gastrocolic ligament from pylorus

Procedure

Primary outcomes

weight loss

Time frame: 12 months postoperative

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Mansoura University

Other

Registry information

Important dates

Primary completion: 2013
First posted: Feb 6, 2013
Registry last updated: Feb 6, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed